EUVIMEDEUVIMED entdecken
Crossref

Xanthohumol Regulates Mitophagy in Osteosarcoma Cells via AMPK ‐ ULK1 ‐ FUNDC1 Signaling Pathway

Qiaofeng Ge, Zhiliang Yan, Qian Tian, Jiyan Zhang, Jia Li, Fang Cai, Long Zhang, Yonggang Zhu iD

Phytotherapy Research · 2025-05 · 39 (5) · 2393-2406

DOI: 10.1002/ptr.8468 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytotherapy Research, online erschienen am 07.04.2025. Verfasst von Qiaofeng Ge und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traumatic Orthopedics, Xi'an People's Hospital (Xi'an Fourth Hospital), Xi'an, Shanxi, China. Hauptthemen laut MEDLINE: Mitophagy, Osteosarcoma, Flavonoids, Propiophenones. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: The Research Incubation Fund of Xi'an People's Hospital, Zhejiang Province Medicine Science and Technology Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Osteosarcoma (OS) is the most common primary bone malignancy. The therapeutic efficacy for OS patients has remained stagnant in recent decades. Xanthohumol (XN), a flavonoid naturally found in hops, has demonstrated significant anticancer properties in lung and breast cancer. However, its effect on OS and the underlying molecular mechanisms remains uncertain. Therefore, the purpose of this study is to explore the relationship between XN and OS. Firstly, we assessed the impact of XN on OS cell proliferation and migration using CCK‐8, wound‐healing, transwell, and clonogenicity assays. Subsequently, we examined the effect of XN on mitophagy in OS cells through flow cytometry, immunofluorescence, transmission electron microscopy, and western blot analysis. Finally, we constructed siRNA targeting AMPK to validate the pathway. In vitro, we demonstrated that XN inhibited the proliferation and migration of OS cells in a concentration‐ and time‐dependent manner. Furthermore, XN induced mitochondrial damage in OS cells and increased reactive oxygen species (ROS) levels. RNA‐seq analysis suggested a potential mitophagy pathway, which we confirmed experimentally by showing that XN reduced ATP levels, altered mitochondrial membrane potential, and increased the expression of Atg5, Beclin‐1, and LC3 proteins. Interestingly, the mitophagy inhibitor Mdivi‐1 reversed the damage caused by XN to OS cells. Furthermore, we found that XN induced mitophagy and exerted anti‐OS effects through the activation of the AMPK‐ULK1‐FUNDC1 signaling pathway, which was effectively reversed after AMPK knockdown. In vivo, we demonstrated the therapeutic potential of XN using a subcutaneous OS nude mouse model without any organ toxicity. XN emerges as a promising pharmaceutical agent for targeting OS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MitophagyOsteosarcomaFlavonoidsPropiophenonesAutophagy-Related Protein-1 HomologAMP-Activated Protein KinasesMembrane ProteinsMitochondrial ProteinsBone NeoplasmsIntracellular Signaling Peptides and ProteinsHumansSignal TransductionAnimalsCell Line, TumorCell ProliferationReactive Oxygen SpeciesCell MovementMiceMice, NudeMice, Inbred BALB CMembrane Potential, Mitochondrial

Stichwörter der Autor:innen

AMPK‐ULK1‐FUNDC1cell deathmitophagyosteosarcomaxanthohumol

Substanzen

xanthohumolFlavonoidsPropiophenonesAutophagy-Related Protein-1 HomologReactive Oxygen SpeciesAMP-Activated Protein KinasesULK1 protein, humanMembrane ProteinsMitochondrial ProteinsIntracellular Signaling Peptides and Proteins

Autor:innen und Institutionen

  • Department of Traumatic Orthopedics, Xi'an People's Hospital (Xi'an Fourth Hospital), Xi'an, Shanxi, China.
  • Department of Cardiac Diseases, Xi'an People's Hospital (Xi'an Fourth Hospital), Xi'an, Shanxi, China.
  • Center for Rehabilitation Medicine, Department of Anesthesiology, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.
  • Department of Pain, Zhejiang Provincial People's Hospital, Affiliated People's Hospital of Hangzhou Medical College, Hangzhou, Zhejiang, China.

ORCID-Profile: Yonggang Zhu

Förderung

  • The Research Incubation Fund of Xi'an People's Hospital
  • Zhejiang Province Medicine Science and Technology Project

Zitieren

APA

Ge, Q., Yan, Z., Tian, Q., Zhang, J., Li, J., Cai, F., Zhang, L., & Zhu, Y. (2025). Xanthohumol Regulates Mitophagy in Osteosarcoma Cells via AMPK ‐ ULK1 ‐ FUNDC1 Signaling Pathway. Phytotherapy Research, 39(5), 2393-2406. https://doi.org/10.1002/ptr.8468

Vancouver

Ge Q, Yan Z, Tian Q, Zhang J, Li J, Cai F, et al. Xanthohumol Regulates Mitophagy in Osteosarcoma Cells via AMPK ‐ ULK1 ‐ FUNDC1 Signaling Pathway. Phytotherapy Research. 2025;39(5):2393-2406. doi:10.1002/ptr.8468

BibTeX
@article{Ge2025,
  author = {Ge, Qiaofeng and Yan, Zhiliang and Tian, Qian and Zhang, Jiyan and Li, Jia and Cai, Fang and Zhang, Long and Zhu, Yonggang},
  title = {Xanthohumol Regulates Mitophagy in Osteosarcoma Cells via AMPK ‐ ULK1 ‐ FUNDC1 Signaling Pathway},
  journal = {Phytotherapy Research},
  year = {2025},
  volume = {39},
  number = {5},
  pages = {2393--2406},
  doi = {10.1002/ptr.8468}
}
Kostenlos starten →